IJMS | Free Full-Text | Toll-like Receptor Signaling Inhibitory Peptide Improves Inflammation in Animal Model and Human Systemic Lupus Erythematosus
Lupus-prone (NZBxNZW)F 1 mice develop a severe and chronic skin disease... | Download Scientific Diagram
Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice: Molecular Therapy - Methods & Clinical Development
Assessing Lupus‐Like Disease in Murine Model Systems - Lee - 2021 - Current Protocols - Wiley Online Library
Head-to-head comparative pharmacokinetic and biodistribution (PK/BD) study of two dexamethasone prodrug nanomedicines on lupus-prone NZB/WF1 mice - ScienceDirect
Contribution of mouse models in our understanding of lupus
23 Treating lupus-prone mice with a coenzyme Q10 analog decreases disease parameters indicating a therapeutic role in systemic lupus erythematosus | Lupus Science & Medicine
PD-1H (VISTA)–mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus | Science Translational Medicine
Frontiers | Humanized Mouse Models of Systemic Lupus Erythematosus: Opportunities and Challenges
Polymeric dexamethasone prodrugs attenuate lupus nephritis in MRL/lpr mice with reduced glucocorticoid toxicity - ScienceDirect
Amelioration of disease in lupus-prone MRL/lpr mice treated with KN-93,... | Download Scientific Diagram
Murine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity | PNAS
The Microbiome and Systemic Lupus Erythematosus | NEJM